Pharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid Receptors
about
Stimuli of sensory-motor nerves terminate arterial contractile effects of endothelin-1 by CGRP and dissociation of ET-1/ET(A)-receptor complexesBi- or multifunctional opioid peptide drugs.Opioid-receptor-heteromer-specific trafficking and pharmacology.Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic.Effects of the novel, selective and low-efficacy mu opioid receptor ligand NAQ on intracranial self-stimulation in rats.Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5.Mu opioid mediated discriminative-stimulus effects of tramadol: an individual subjects analysisDesign, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents.Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.Synthesis and pharmacological evaluation of hydrophobic esters and ethers of butorphanol at opioid receptors.Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice.Contribution of Endogenous Spinal Endomorphin 2 to Intrathecal Opioid Antinociception in Rats Is Agonist Dependent and Sexually Dimorphic.A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia.Pharmacological Profiles of Oligomerized μ-Opioid Receptors.Structure selectivity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives toward the development of the mu opioid receptor antagonists.Allosteric modulation model of the mu opioid receptor by herkinorin, a potent not alkaloidal agonist.Rapid access to morphinones: removal of 4, 5-ether bridge with Pd-catalyzed triflate reduction.Univalent and bivalent ligands of butorphan: characteristics of the linking chain determine the affinity and potency of such opioid ligands.Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors.Nanoconjugated NAP as a Potent and Periphery Selective Mu Opioid Receptor Modulator To Treat Opioid-Induced Constipation.
P2860
Q33598651-FBD74727-F5C9-4508-8E69-2580546C27DEQ33767037-607A6541-744E-43FB-9845-8B9179938DF9Q33978499-58FA97B3-F296-4408-8999-ACB314910889Q34559481-1D0CA620-3C56-4425-A573-74E64EC2334EQ35027648-12E48FEE-5784-4FB4-B6EA-511E580AD88EQ35220086-8C797FDD-3A5E-40D3-8B08-20637FE33B0DQ36130597-19DDF8B7-27F5-4555-8D26-B8612B14E865Q36480105-78B9AC27-3D2A-4F43-933E-565272CABE9DQ36499673-E274E00D-9B73-411B-A079-B1F6CF3A7246Q37349472-FB77CCF4-C45C-4358-9545-90A16E47D57FQ37361349-E7704A0A-1A1A-4A48-AF54-07923F0627DFQ37380071-5A040A32-850C-4D60-8D1F-2FEBC35860BDQ37570243-B6C0C4F2-A8EA-4A02-826E-0C66949D00BDQ37679197-D4A77A4F-F635-4794-A491-F5C4141DA72AQ38373652-AD0B42CE-C4DF-4C4E-AB7A-215A1CB6097DQ38736870-7F93EEB9-75BB-490E-BB9A-47A2E524E66EQ40632677-916CE732-202B-4C3A-BAC1-3ABD523E52C0Q41956244-267F4F4B-5D52-4F38-8F13-F96111D6AE4BQ42734840-9084D2D7-3934-4A48-8341-F9E3BB82AD89Q44342749-D7A75777-C8B0-4C0F-97FC-5197CE2C8CC2
P2860
Pharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid Receptors
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Pharmacological Properties of ...... t μ, δ, and κ Opioid Receptors
@ast
Pharmacological Properties of ...... t μ, δ, and κ Opioid Receptors
@en
type
label
Pharmacological Properties of ...... t μ, δ, and κ Opioid Receptors
@ast
Pharmacological Properties of ...... t μ, δ, and κ Opioid Receptors
@en
prefLabel
Pharmacological Properties of ...... t μ, δ, and κ Opioid Receptors
@ast
Pharmacological Properties of ...... t μ, δ, and κ Opioid Receptors
@en
P2093
P2860
P921
P356
P1476
Pharmacological Properties of ...... t μ, δ, and κ Opioid Receptors
@en
P2093
Brian I. Knapp
Jean M. Bidlack
John L. Neumeyer
Xuemei Peng
P2860
P304
P356
10.1021/JM061327Z
P407
P577
2007-05-01T00:00:00Z